BioSpace News Archive

Researchers Discover Candida auris Can Reproduce Sexually

A deadly fungus–Candida auris (C. auris)–has shaken up the biological world with its ability to reproduce sexually. What can be its dangers and what are the next steps? Know it all here.

June 29, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Business

Money on the Move: ReCode, MiroBio & More Target Technology

This week money went towards more advanced rounds of financing for drugs and technology that have already shown a lot of promises.

June 29, 2022
·
4 min read
·
Hannah Chudleigh
Drug Development

Global Roundup: Italfarmaco Makes Progress against DMD, Clover Scores on Omicron

Italfarmaco is making headway against DMD as it announced positive results from a Phase III study, Clover’s homologous booster against Omicron increases antibodies, and much more.

June 29, 2022
·
5 min read
·
Alex Keown
Drug Development

BioNTech and Pfizer to Begin Testing Universal Coronavirus Vaccine

BioNTech announced it is partnering with Pfizer to begin testing a next-generation universal vaccine against coronaviruses, including SARS-CoV-2, the coronavirus that causes COVID-19.

June 29, 2022
·
4 min read
·
Mark Terry
Policy

FDA Advisory Committee Calls For Updated COVID-19 Boosters to Quell Omicron

Voting 19-2, the Vaccines and Related Biological Products Advisory Committee favored redesigning booster shots to include the coronavirus’ Omicron variant.

June 29, 2022
·
2 min read
·
Tristan Manalac
Drug Development

Icosavax Preps IND Application for RSV Vaccine Following Positive Data

Icosavax posted positive topline interim data from its Phase I/Ib trial of IVX-121, its candidate virus-like particle vaccine against the respiratory syncytial virus in young and older adults.

June 29, 2022
·
2 min read
·
Vanessa Doctor, RN
ARCH Defies Biotech Market Slowdown with New $3B Fund

“Science doesn’t care what markets are doing, and science moves forward,” ARCH Co-founder and Managing Director Robert Nelsen said in a statement.

June 29, 2022
·
3 min read
·
Mark Terry
Business

Generian, Mitobridge (Astellas) Partner to Expand Playbook of what is Druggable

Generian and Mitobridge, a wholly-owned subsidiary of Astellas Pharma, announced a collaboration to discover and develop novel small molecules for undruggable therapeutic targets.

June 29, 2022
·
4 min read
·
Hayley Shasteen
New Research Explores the Role of Oxygen in Cancer Growth

New research by investigators at Columbia University and MIT describes how cancer cells often depend upon the importation of fat for continued growth and division.

June 29, 2022
·
3 min read
·
Mark Terry
Policy

Leaders Weigh in on how the Fall of Roe Will Affect Biopharma

As the nation reacts to the overturning of Roe v. Wade, pharma companies must address the changes in demand for drugs and services, all while navigating increasingly muddy legal waters.

June 29, 2022
·
6 min read
·
Rosemary Scott